Late effects of therapy for Hodgkin's lymphoma

Current Hematologic Malignancy Reports

Volumn 2, Issue 3, 2007, Pages 143-150

  Adams, Michael Jacob ^b   Constine, Louis S ^b   Lipshultz, Steven E ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; ORAL CONTRACEPTIVE AGENT; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

ACUTE GRANULOCYTIC LEUKEMIA; BREAST CANCER; CANCER RADIOTHERAPY; CARDIOMYOPATHY; COMBINATION CHEMOTHERAPY; DIGESTIVE SYSTEM CANCER; DOSE RESPONSE; FEMALE INFERTILITY; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HODGKIN DISEASE; HUMAN; LEUKEMIA; LUNG CANCER; LUNG DISEASE; LUNG INJURY; MALE INFERTILITY; MENSTRUAL IRREGULARITY; MULTIPLE CYCLE TREATMENT; OVARY INSUFFICIENCY; PNEUMONIA; QUALITY OF LIFE; REVIEW; SARCOMA; SECONDARY AMENORRHEA; THYROID CANCER; THYROID DISEASE; VALVULAR HEART DISEASE;

ADOLESCENT; ADULT; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARDIOVASCULAR DISEASES; FATIGUE; FEMALE; HODGKIN DISEASE; HUMANS; HYPOTHYROIDISM; INFERTILITY; LEUKEMIA, RADIATION-INDUCED; MALE; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; QUALITY OF LIFE; RADIATION PNEUMONITIS; RADIOTHERAPY; RISK; SURVIVORS; TIME FACTORS;

EID: 34547779083     PISSN: 15588211     EISSN: 1558822X     Source Type: Journal    
DOI: 10.1007/s11899-007-0020-4     Document Type: Review

References (52)

1. Ries LAG, Eisner MP, Kosary C, et al.: SEER Cancer Statistics Review, 1973-2001. Bethesda, MD: National Cancer Institute; 2004.
2. Mauch P, Kalish LA, Marcus KC, et al.: Long-term survival in Hodgkin's disease: relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am 1995, 1:33-42.
3. van Leeuwen FE, Klokman WJ, Veer MB, et al.: Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 2000, 18:487-497.
4. Bhatia S, Yasui Y, Robison LL, et al.: High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol 2003, 21:4386-4394.
5. Ng AK, Bernardo MV, Weller E, et al.: Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 2002, 100:1989-1996.
6. Chronowski GM, Wilder RB, Levy LB, et al.: Second malignancies after chemotherapy and radiotherapy for Hodgkin disease. Am J Clin Oncol 2004, 27:73-80.
7. Dores GM, Metayer C, Curtis RE, et al.: Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 2002, 3484-3494.
8. van Leeuwen FE, Klokman WJ, Stovall M, et al.: Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 2003, 95:971-980.
9. Travis LB, Gospodarowicz M, Curtis RE, et al.: Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 2002, 94:182-192.
10. Hancock SL, Tucker MA, Hoppe RT: Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 1993, 85:25-31.
11. Bhatia S, Robison LL, Oberlin O, et al.: Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996, 334:745-751.
12. Travis LB, Hill D, Dores GM, et al.: Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst 2005, 97:1428-1437.
13. Kenney LB, Yasui Y, Inskip PD, et al.: Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med 2004, 141:590-597.
14. Aisenberg AC, Finkelstein DM, Doppke KP, et al.: High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer 1997, 79:1203-1210.
15. Travis LB, Hill DA, Dores GM, et al.: Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003, 290:465-475.
16. • Hill DA, Gilbert E, Dores GM, et al.: Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors. Blood 2005, 106:3358-3365. Case-control sudy nested within very large cohort (same population as studied in references 12 and 15), which explored role of traditional breast cancer risk factors in survivors of HL.
17. Albrektsen G, Heuch I, Kvale G: The short-term and long-term effect of a pregnancy on breast cancer risk: a prospective study of 802,457 parous Norwegian women. Br J Cancer 1995, 72:480-484.
18. Adams MJ, Lipshultz SE: Pathophysiology of anthracycline-and radiation-associated cardiomyopathies: implications for screening and prevention. Pediatr Blood Cancer 2005, 44:600-606.
19. Hancock SL, Hoppe RT: Long-term complications of treatment and causes of mortality after Hodgkin's disease. Semin Radiat Oncol 1996, 6:225-242.
20. Aleman BM, van den Belt-Dusebout AW, Klokman WJ, et al.: Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 2003, 21:3431-3439.
21. Aleman BM, van den Belt-Dusebout AW, De Bruin ML, et al.: Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 2007, 109:1878-1886.
22. Lee CK, Aeppli D, Nierengarten ME: The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin's disease: University of Minnesota experience. Int J Radiat Oncol Biol Phys 2000, 48:169-179.
23. Hancock SL, Tucker MA, Hoppe RT: Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993, 270:1949-1955.
24. Hancock SL, Donaldson SS, Hoppe RT: Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 1993, 11:1208-1215.
25. Reinders JG, Heijmen BJ, Olofsen-van Acht MJ, et al.: Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up. Radiother Oncol 1999, 51:35-42.
26. Boivin J-F, Hutchison G, Lubin J, Mauch P: Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 1992, 69:1241-1247.
27. Heidenreich PA, Schnittger I, Strauss HW, et al.: Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol 2007, 25:43-49.
28. • Adams MJ, Lipsitz SR, Colan SD, et al.: Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 2004, 22:3139-3148. The most comprehensive cardiac function screening of an HL cohort reported in a single article.
29. ** Heidenreich PA, Hancock SL, Vagelos RH, et al.: Diastolic dysfunction after mediastinal irradiation. Am Heart J 2005, 150:977-982. The cohort screened in this paper was the same as the one in reference 27 and an earlier paper by this group. Together, these papers represent the most comprehensive longitudinal cardiovascular screening of HL survivors reported to date.
30. Iarussi D, Pisacane C, Indolfi P, et al.: Evaluation of left ventricular function in long-term survivors of childhood Hodgkin disease. Pediatr Blood Cancer 2005, 45:700-705.
31. Swerdlow AJ, Higgins CD, Smith P, et al.: Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst 2007, 99:206-214.
32. Bowers DC, McNeil DE, Liu Y, et al.: Stroke as a late treatment effect of Hodgkin's disease: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2005, 23:6508-6515.
33. Bilora F, Pietrogrande F, Petrobelli F, et al.: Is radiation a risk factor for atherosclerosis? An echo-color Doppler study on Hodgkin and non-Hodgkin patients. Tumori 2006, 92:295-298.
34. Horning SJ, Adhikari A, Rizk N, et al.: Effect of treatment for Hodgkin's disease on pulmonary function: results of a prospective study. J Clin Oncol 1994, 12:297-305.
35. Friedman DL, Constine LS: Late effects of treatment for Hodgkin lymphoma. J Natl Comp Cancer Netw 2006, 4:249-257.
36. Martin WG, Ristow KM, Habermann TM, et al.: Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma. J Clin Oncol 2005, 23:7614-7620.
37. Knobel H, Havard LJ, Brit LM, et al.: Late medical complications and fatigue in Hodgkin's disease survivors. J Clin Oncol 2001, 19:3226-3233.
38. Sklar C, Whitton J, Mertens A, et al.: Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2000, 85:3227-3232.
39. Metzger ML, Hudson MM, Somes GW, et al.: White race as a risk factor for hypothyroidism after treatment for pediatric Hodgkin's lymphoma. J Clin Oncol 2006, 24:1516-1521.
40. Sklar CA, Mertens AC, Mitby P, et al.: Premature menopause in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2006, 98:890-896.
41. Chemaitilly W, Mertens AC, Mitby P, et al.: Acute ovarian failure in the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2006, 91:1723-1728.
42. Behringer K, Breuer K, Reineke T, et al.: Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol 2005, 23:7555-7564.
43. Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S: Hodgkin's disease survivors more fatigued than the general population. J Clin Oncol 1999, 17:253-261.
44. Mols F, Vingerhoets AJ, Coebergh JW, et al.: Better quality of life among 10-15 year survivors of Hodgkin's lymphoma compared to 5-9 year survivors: a population-based study. Eur J Cancer 2006, 42:2794-2801.
45. Hjermstad MJ, Fossa SD, Oldervoll L, et al.: Fatigue in long-term Hodgkin's disease survivors: a follow-up study. J Clin Oncol 2005, 23:6587-6595.
46. Hjermstad MJ, Oldervoll L, Fossa SD, et al.: Quality of life in long-term Hodgkin's disease survivors with chronic fatigue. Eur J Cancer 2006, 42:327-333.
47. Ng AK, Li S, Recklitis C, et al.: A comparison between long-term survivors of Hodgkin's disease and their siblings on fatigue level and factors predicting for increased fatigue. Ann Oncol 2005, 16:1949-1955.
48. Donaldson SS, Link MP, Weinstein HJ, et al.: Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. J Clin Oncol 2007, 25:332-337.
49. Chow LM, Nathan PC, Hodgson DC, et al.: Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation. J Clin Oncol 2006, 24:5735-5741.
50. •• Children's Oncology Group: Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers (Ver. 2.0, 2006). http://www.survivorship-guidelines.org/. Accessed March 2007. Reference for care of childhood cancer survivors, which also can be interpreted to assist with survivors treated as young adults.
51. Saslow D, Boetes C, Burke W, et al.: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007, 57:75-89.
52. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol In Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.